SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-12-031365
Filing Date
2012-05-01
Accepted
2012-05-01 15:42:01
Documents
2
Group Members
ASTRAZENECA HOLDINGS BVASTRAZENECA INTERMEDIATE HOLDINGS LTDASTRAZENECA TREASURY LTDASTRAZENECA UK LTDZENECA HOLDINGS INC.ZENECA INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D a12-10931_1sc13d.htm SC 13D 333593
2 EX-3 a12-10931_1ex3.htm EX-3 32040
  Complete submission text file 0001104659-12-031365.txt   367572
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121 858-652-6500
Ardea Biosciences, Inc./DE (Subject) CIK: 0001103390 (see all company filings)

IRS No.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-59411 | Film No.: 12800403
SIC: 2834 Pharmaceutical Preparations